Download This program is designed for individuals who may be

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Immunomics wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Common cold wikipedia , lookup

Innate immune system wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Urinary tract infection wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Schistosomiasis wikipedia , lookup

Chickenpox wikipedia , lookup

Infection wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Coccidioidomycosis wikipedia , lookup

Neonatal infection wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Infection control wikipedia , lookup

Hepatitis C wikipedia , lookup

Hepatitis B wikipedia , lookup

Transcript
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page i
Blood-borne Pathogens – Comprehensive Course
This program is designed for individuals who may be exposed to blood and body
fluids during the performance of their work and who wish to gain a more thorough
understanding of blood-borne pathogens.
The primary objectives for the Blood-borne Pathogens course are:


to provide participants with the information required to recognize the
hazards associated with occupational exposure to blood and body fluids
become familiar with the steps to prevent exposure to blood and body
fluids as well as the steps that should be taken following exposure to
blood and body fluids
Course Content:
The Blood-borne Pathogens Course consists of 9 modules. The outline for the
course material is as follows:
Module 1: Introduction to Blood-borne Pathogens
Module 2: The Immune System
Module 3: Defence – The Immune System at Work
Module 4: Anatomy, Physiology and Pathophysiology of the Liver
Module 5: Hepatitis B Virus (HBV)
Module 6: Hepatitis C Virus (HCV)
Module 7: Human Immunodeficiency Virus (HIV)
Module 8: Prevention of Blood-borne Pathogen Exposure
Module 9: Blood and Body Fluid Exposure Follow-up
Evaluation Process
At the end of each module, there is a quiz that each course participant must
challenge and successfully complete with a passing grade before continuing to
the next content module. Module quizzes are review and evaluation tools that
assist in preparing the course participant for the formal timed examinations
following completion of Modules 4, 7 and 9, followed by a final exam. These
exams consist of the following:
Tests (3) (Modules 1-4, Modules 5-7, and Modules 8-9)
Final Exam (Modules 1-9)
** Pass mark for each examination is 80% **
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page ii
Upon completion of the Blood-borne Pathogens Course the participant will be
able to:




Describe the hazards associated with exposure to blood and body fluids.
Describe the most common blood-borne pathogens.
Describe methods and protocols to prevent exposure to blood-borne
pathogens.
Describe the appropriate steps that should be taken following exposure to
blood and body fluids.
Objectives:
Module 1: Introduction to Blood-borne Pathogens
 Define the term pathogen.
 Define the term blood-borne.
 Be familiar with the main groups of pathogens.
 Define the three most common occupationally acquired blood-borne
pathogens.
 Define and differentiate the terms exposure and infection.
 Describe what constitutes significant exposure.
 Define occupational exposure.
 Describe the routes by which BBP can enter the body.
 Define percutaneous.
 Describe mucous-membranes.
 Define prophylactic.
 Define the term hepatitis.
 Describe the individuals most at risk of acquiring infection involving bloodborne pathogens.
 Discuss the procedures associated with the highest risk of BBP
transmission.
 Discuss the relevance of injection practices with respect to BBP
transmission.
 Be familiar with the types of body fluids known to transmit or have the
potential to transmit blood-borne pathogens.
 Be familiar with the types of body fluids not associated with blood-borne
transmission.
 Discuss the importance of vaccine with respect to HBV, HCV and HIV.
 Be familiar with factors that affect risk of transmission and infection
following exposure.
 Describe the procedures most at risk for occupational exposure to bloodborne pathogen.
 Be familiar with factors that affect the risk of transmission and infection
following exposure.
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page iii
Module 2: The Immune System
 Be familiar with the organs and tissues included in the immune system.
 Be familiar with the three major functions of the immune system.
 Discuss the structure and function of lymph nodes.
 Be familiar with the different types of white blood cells (WBCs).
 Demonstrate a general understanding of the different types of WBCs.
 Describe the functions of macrophages.
 Demonstrate an understanding of the flow of lymph fluid.
 Define antigen and antibody.
 Differentiate the terms ‘self’ and ‘non-self’.
 Differentiate donor and recipient.
 Name the types of materials and substances that may be recognized as
foreign antigens.
 Define immunity, compatibility, autoimmune disease,
immunosuppressants, phagocytes, interstitial fluid and stem cells.
 Differentiate specificity and non-specificity.
 Be familiar with the terms cytokine and chemotaxin.
 Name the four main types of lymphocytes.
 Demonstrate an understanding of cluster of differentiation antigens.
Module 3: Defence – The Immune System at Work
 Differentiate innate and acquired immunity.
 Differentiate active, passive and induced immunity.
 Demonstrate an understanding of antibody production, recognition and
presentation.
 Be familiar with the function of NK cells.
 Differentiate T-cells and B-cells.
 Differentiate humoral and cell-mediate immunity.
 Be familiar with the purpose of complement proteins.
 Be familiar with MHC proteins.
 Describe the three types of T-cells.
 Be familiar with CD proteins found on TC-cells and TH-cells.
 Describe the function of TH-cells, TC-cells and TS-cells
 Demonstrate an understanding of memory cells.
 Be familiar with the cytokines, especially interferon and histamine.
 Describe the function of the membrane attack complex.
 Demonstrate an understanding of immune response to viral invasion and
bacterial invasion.
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page iv
Module 4: Anatomy, Physiology and Pathophysiology of the Liver
 Define and be able to differentiate the terms anatomy, physiology, and
Pathophysiology and pathogenesis.
 Be familiar with the previous names for HAV, HBV and HCV.
 Describe the function of the liver.
 Properly label a simple diagram of the biliary tract.
 Describe the function of the gall bladder.
 Describe bilirubin and where it originates.
 Describe bile.
 Describe the role of bile with respect to fat metabolism.
 Define metabolism.
 Define hepatocyte.
 Differentiate liver lobes, lobules and hepatocytes.
 Differentiate canaliculi, ductules and ducts.
 Discuss the role of the liver with respect to metabolism, detoxification, and
waste removal.
 Describe the function of the liver with respect to glucose, fats and proteins.
 Name the three types of fat synthesized by the liver.
 Name the three main groups of proteins produced by the liver.
 Define enzyme.
 Describe the importance of cholesterol in metabolic processes.
 Demonstrate understanding of liver function with respect to blood
coagulation.
 Name the two major categories of liver proteins.
 Differentiate glucose and glycogen.
 Define co-infection and superinfection.
 Name the two most common causes of hepatocyte injury.
 Define the terms acute and chronic.
 Define hepatitis.
 Be familiar with the clinical presentation of acute hepatitis.
 Define carrier state.
 Be familiar with blood tests commonly used to monitor liver function.
 Name four causes of liver damage.
 Be familiar with the risks associated with acquiring HAV, HBV and HCV
infection.
 Be familiar with the mode of transmission for HAV, HBV, HCV, HDV and
HEV.
 Define fulminant liver disease.
 Define necrosis.
 Describe the long term complications associated with HBV, HCV, and HIV
infection.
 Describe the complications associated with chronic infection.
 Define the term cirrhosis.
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page v
Module 5: Hepatitis B Exposure
 Describe the routes of transmission associated with HBV infection.
 Describe the effect of HBV on the liver.
 Define and differentiate between the terms epidemiology, incidence, and
prevalence.
 Be familiar with the term ‘Dane particle.’
 Be familiar with the three major HBV antigens.
 Describe the incubation period for HBV infection.
 Define the term carrier.
 Describe the risk of developing chronic HBV infection.
 Describe the risk of developing HBV infection following percutaneous
injury.
 Be familiar with the incidence and prevalence of HBV infection.
 Describe the symptoms and clinical presentation associated with HBV
infection.
 Describe the complications associated with HBV infection.
 Be familiar with the treatments for acute and chronic hepatitis.
 Describe the role of prophylactic treatment with respect to prevention of
HBV infection following exposure to blood or body fluids.
 Describe safety measures associated with prevention of HBV exposure.
 Define the risk of developing HBV infection following exposure.
 Describe safety measures associated with prevention of HBV infection
following exposure.
 Define fulminant hepatitis and cirrhosis.
 Be familiar with the laboratory blood tests used to diagnose and monitor
HBV infection.
 Describe the role of immunization with respect to prevention of HBV
infection.
 Discuss the role of re-immunization and booster shots following initial
HBV. immunization.
 Describe the role of immunity testing following HBV exposure.
 Describe the efficacy of immunization with respect to immune response.
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page vi
Module 6: Hepatitis C Exposure
 Describe the routes of transmission for HCV exposure/infection.
 Describe the effect of HCV on the liver.
 State the prevalence of HCV infection in the population.
 Discuss the most common risk factors associated with HCV infection.
 Describe the role of donated blood or blood products in HCV transmission.
 Describe the role of hemodialysis in HCV transmission.
 What is the incubation period for HCV infection.
 Describe the symptoms and manifestations of acute HCV infection.
 Describe the complications associated with chronic HCV infection.
 Define the risk of developing chronic HCV infection following acute
infection.
 Describe the role of prophylactic treatment with respect to prevention of
HCV.
 Define the risk of developing HCV infection following exposure.
 Describe the role of immunization with respect to prevention of HCV
infection.
 Discuss the difficulties associated with HCV vaccine development.
 Be familiar with the treatment goal(s) for HCV.
 Discuss the two most common anti-viral agents used to treat chronic HCV
infection, and common side-effects.
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page vii
Module 7: HIV Exposure
 Describe the routes of transmission associated with HIV infection.
 State the prevalence of HIV infection in the population.
 Describe the incubation period preceding seroconversion in individuals
exposed to HIV.
 Describe the incubation period preceding symptoms of HIV infection.
 Describe the symptoms and manifestations of acute HIV infection.
 Describe the complications associated with chronic HIV infection.
 Define the risk of developing HIV infection following exposure.
 Describe the role of prophylactic treatment with respect to prevention of
HIV infection following exposure to blood or body fluids.
 Describe safety measures associated with prevention of HIV exposure.
 Describe safety measures associated with prevention of HIV infection
following exposure.
 Describe the role of immunization with respect to prevention of HIV
infection.
 Define and differentiate HIV infection, Aids-related complex, and acute
immunodeficiency syndrome.
 Be familiar with the treatment for hepatitis C.
 Describe the role of prophylactic treatment following exposure to HIV.
 Describe the current role of immunization with respect to prevention of HIV
infection.
 Define and differentiate between HIV screening tests and confirmatory
tests.
Module 8: Prevention of Blood-borne Pathogen Exposure
 Describe the government regulations and workplace policies created to
reduce occupational exposure to blood-borne pathogens.
 Define Body Substance Isolation.
 Define and differentiate the terms Universal Precautions and Standard
Precautions.
 Describe employer responsibilities in prevention of occupational exposure
to blood-borne pathogens.
 Define employee responsibilities in prevention of occupational exposure to
blood-borne pathogens.
 Describe the main issues targeted in the Blood-borne Pathogen
Regulations.
 Describe practical methods to prevent needle-stick and sharps exposures.
 Describe the role of workplace Exposure Control Plans in preventing
exposure to blood-borne pathogens.
 Describe the components that should be included in a workplace
Exposure Control Plan.
ARO Training & Consulting
Bloodborne Pathogens
Bloodborne Pathogens Course Overview
Page viii
Module 9: Blood and Body Fluid Exposure Follow-up
 Describe the steps that should be performed following an exposure to
blood or body fluids.
 Describe the role of the workplace Occupational Health department in
blood and body fluid exposure follow-up.
 Describe the laboratory testing that may be appropriate following an
occupational exposure to blood or body fluids.
 Describe the relative risk of infection following exposure to blood or body
fluids from an individual who is positive for HBV, HCV, or HIV.
 Describe the factors and considerations that influence blood-borne
pathogen infection following exposure to blood and body fluids from an
individual who is positive for HBV, HCV, or HIV.